US Bancorp
KRRO icon

US Bancorp’s Korro Bio KRRO Stock Holding History

US Bancorp’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-87
Closed -$3.31K – 4296
2024
Q4 		$3.31K Buy
87
+2
+2% +$103 ﹤0.01% 3748
2024
Q3 		$2.84K Buy
85
+12
+16% +$505 ﹤0.01% 3709
2024
Q2 		$2.47K Buy
+73
New +$4.03K ﹤0.01% 3680
2021
Q4 		– Sell
-4
Closed -$2K – 4172
2021
Q3 		$2K Sell
4
-38
-90% -$15K ﹤0.01% 3891
2021
Q2 		$21K Buy
+42
New +$20.5K ﹤0.01% 3113

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

US Bancorp's KRRO Position: Q1 2025 in Review

US Bancorp sold out of Korro Bio (KRRO) in Q1 2025, closing a stake of 87 shares — an estimated $3.31K sold.

US Bancorp first reported a position in KRRO in Q2 2021 and held it in 5 quarters. The position peaked at $21K in Q2 2021. 75 funds tracked by Wall St. Rank hold KRRO as of Q1 2025.

  • US Bancorp reported no remaining Korro Bio position as of Q1 2025 after selling out during the quarter.
  • US Bancorp sold 87 Korro Bio shares in Q1 2025, an estimated $3.31K.
  • US Bancorp first reported a position in Korro Bio in Q2 2021 and held it in 5 quarters.
  • US Bancorp's Korro Bio position peaked at $21K in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Korro Bio as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.